Liposomal Delivery of P-Ethoxy Antisense Oligodeoxynucleotides in Chronic Myelogenous Leukemia

作者: A. M. Tari , N. Neamati , M. Andreeff , G. Lopez-Berestein

DOI: 10.1007/978-1-4615-6405-8_17

关键词:

摘要: Liposomes have been used widely as drug delivery vehicles. Recently, we focused our studies on the liposomal of nucleic acids. We and others reported feasibility using liposomes to deliver various acid analogues, such phosphodiesters (Thierry Dritschilo, 1992; Ropert et al, 1993; Thierry Tari 1995), phosphorothioates Bennett Busch 1994; Lappalainen 1994), methyl phosphonates (Tari 1994). In this chapter, will present findings another analogue, P-ethoxy oligodeoxynucleotides (oligos). oligos are uncharged analogues in which an ethyl group has added nonbridging oxygen atom phosphate bonds. P-ethoxys were first synthesized by (1971) found be resistant against nuclease digestion (Miller 1974) could bind DNA with higher binding affinity than their phosphodiester counterparts 1971).

参考文章(21)
D Cortez, L Kadlec, A M Pendergast, Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Molecular and Cellular Biology. ,vol. 15, pp. 5531- 5541 ,(1995) , 10.1128/MCB.15.10.5531
Franklin H. Epstein, Razelle Kurzrock, Jordan U. Gutterman, Moshe Talpaz, The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias New England Journal of Medicine. ,vol. 319, pp. 990- 998 ,(1988) , 10.1056/NEJM198810133191506
Paul S. Miller, Kai N. Fang, Norman S. Kondo, Paul O. P. Ts'o, Syntheses and properties of adenine and thymine nucleoside alkyl phosphotriesters, the neutral analogs of dinucleoside monophosphates. Journal of the American Chemical Society. ,vol. 93, pp. 6657- 6665 ,(1971) , 10.1021/JA00753A054
C. Ropert, C. Malvy, P. Couvreur, Inhibition of the Friend Retrovirus by Antisense Oligonucleotides Encapsulated in Liposomes: Mechanism of Action Pharmaceutical Research. ,vol. 10, pp. 1427- 1433 ,(1993) , 10.1023/A:1018910922633
AM Tari, SD Tucker, A Deisseroth, G Lopez-Berestein, Liposomal Delivery of Methylphosphonate Antisense Oligodeoxynucleotides in Chronic Myelogenous Leukemia Blood. ,vol. 84, pp. 601- 607 ,(1994) , 10.1182/BLOOD.V84.2.601.601
T Skorski, P Kanakaraj, M Nieborowska-Skorska, MZ Ratajczak, SC Wen, G Zon, AM Gewirtz, B Perussia, B Calabretta, Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood. ,vol. 86, pp. 726- 736 ,(1995) , 10.1182/BLOOD.V86.2.726.BLOODJOURNAL862726
JQ Guo, JY Lian, YM Xian, MS Lee, AB Deisseroth, SA Stass, RE Champlin, M Talpaz, JY Wang, RB Arlinghaus, BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy Blood. ,vol. 83, pp. 3629- 3637 ,(1994) , 10.1182/BLOOD.V83.12.3629.3629
Albert B. Deisseroth, Ralph B. Arlinghaus, Chronic Myelogenous Leukemia: Molecular Approaches to Research and Therapy ,(1990)
J ten Hoeve, RB Arlinghaus, JQ Guo, N Heisterkamp, J Groffen, TYROSINE PHOSPHORYLATION OF CRKL IN PHILADELPHIA+ LEUKEMIA Blood. ,vol. 84, pp. 1731- 1736 ,(1994) , 10.1182/BLOOD.V84.6.1731.1731